Abstract |
|
Authors | Elisabet E Manasanch, Carlos Fernández de Larrea, Adriana Zingone, Seth M Steinberg, Mary Kwok, Nishant Tageja, Manisha Bhutani, Dickran Kazandjian, Mark Roschewski, Peter Wu, George Carter, Diamond Zuchlinski, Marcia Mulquin, Liz Lamping, Rene Costello, Deborah Burton, Lindsay A Gil, William D Figg, Irina Maric, Katherine R Calvo, Constance Yuan, Maryalice Stetler-Stevenson, Neha Korde, Ola Landgren |
Journal | Leukemia & lymphoma
(Leuk Lymphoma)
Vol. 58
Issue 3
Pg. 639-645
(03 2017)
ISSN: 1029-2403 [Electronic] United States |
PMID | 27687480
(Publication Type: Journal Article)
|
Chemical References |
- Biomarkers
- Immunoglobulin Isotypes
- Oligopeptides
- Thalidomide
- carfilzomib
- Dexamethasone
- Proteasome Endopeptidase Complex
- Lenalidomide
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Biomarkers
- Dexamethasone
(administration & dosage)
- Enzyme Activation
- Female
- Humans
- Immunoglobulin Isotypes
(blood)
- Lenalidomide
- Male
- Middle Aged
- Multiple Myeloma
(blood, diagnosis, drug therapy)
- Neoplasm Staging
- Neoplasm, Residual
(diagnosis)
- Oligopeptides
(administration & dosage)
- Proteasome Endopeptidase Complex
(blood)
- Thalidomide
(administration & dosage, analogs & derivatives)
- Treatment Outcome
|